We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




Machine Learning Model Shows Promise for Improving Metanephrine Testing Accuracy

By LabMedica International staff writers
Posted on 30 Jul 2026

Pheochromocytomas and paragangliomas are rare tumors that form in or near the adrenal glands and cause overproduction of stress hormones. More...

Plasma-free metanephrines are the recommended first-line test, but mild elevations in people without these tumors can generate false positives and lead to unnecessary follow-up. To improve interpretation, laboratories are investigating machine-learning approaches that contextualize results and improve rule-out accuracy. New findings demonstrate how such models can both enhance and complicate interpretation of metanephrine testing in routine care.

Researchers at Samsung Medical Center (Seoul, South Korea) tested several machine learning (ML) algorithms to augment plasma-free metanephrine testing for suspected pheochromocytoma and paragangliomas (PPGL). The approach combined metanephrine measurements with structured electronic health record (EHR) data to reduce false-positive results. Inputs described in the analysis included kidney and urine biomarkers, medication profiles, and the presence of other diseases.

In a real-world cohort, the team analyzed data from 20,516 adults who underwent metanephrine testing at Samsung Medical Center between 2011 and 2024. Of the 19,797 patients ultimately determined not to have PPGL, 25.2% showed metanephrine elevations that could prompt a false-positive result. Initial ML models suggested that integrating clinical context with metanephrine results improved real-world discrimination and appeared to boost the test’s performance to an excellent level.

Subsequent checks revealed important caveats. Additional analyses indicated that some apparent gains reflected “shortcut learning” from informative missingness, with models inferring clinician suspicion based on which follow-up tests were ordered rather than independent biochemical signal. The investigators emphasized that ML should be judged not only by headline performance metrics but also by whether it learns the intended clinical signal, highlighting the need for external validation and careful audits. 

The findings were presented at the Association for Diagnostics & Laboratory Medicine (ADLM) 2026 meeting in Anaheim, California (Abstract B-091).

“After abstract submission, while testing the prototype app with the developed ML model, we realized that some of the apparent improvement might reflect patterns of clinical workup rather than independent biochemical information. Additional robustness analyses showed that much of the improvement was explained by shortcut learning from informative missingness,” said Se-eun Koo, one of the study’s co-authors and a clinical chemistry fellow in the department of laboratory medicine and genetics at Samsung Medical Center in Seoul, South Korea.

“This study shows that machine learning in laboratory medicine should be evaluated not only by performance metrics, but also by whether the model is learning the intended clinical signal. That is why external validation and careful audits for shortcut learning are so important,” Koo said.

Related Links
Samsung Medical Center 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Gold Member
Automatic Hematology Analyzer
CF9600
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.